Dev Chatterjee &Amp;Amp; Sohini Das

Stories by Dev Chatterjee &Amp;Amp; Sohini Das

Hindujas' RCap purchase hangs fire as deadline looms with payment on hold

Hindujas' RCap purchase hangs fire as deadline looms with payment on hold

Rediff.com   1 Aug 2024

Mauritius-based Hinduja group firm IndusInd International Holdings (IIHL) has informed the administrator of Reliance Capital that it is ready with its equity contribution of Rs 2,750 crore in cash to acquire the bankrupt firm, but it wants certain conditions to be met in accordance with the resolution plan before transferring the amount. IIHL has also filed an application with the Mumbai Bench of the National Company Law Tribunal (NCLT), seeking directions for the administrator and the committee of creditors (CoC) to complete all pending activities to close the transaction and not let the lenders invoke the bank guarantees provided by the firm earlier.

Will Curvv Be An SUV Trend Setter?

Will Curvv Be An SUV Trend Setter?

Rediff.com   31 Jul 2024

'We will have multiple engine options -- electric vehicle and internal combustion engine in diesel and petrol.'

Can Ola Electric Cruise to 6,146 Cr IPO?

Can Ola Electric Cruise to 6,146 Cr IPO?

Rediff.com   30 Jul 2024

The Softbank-backed company has set a price band of Rs 72 to Rs 76 per share for the maiden share sale and is expected to test the appetite for new-age loss-making companies.

India's First Dengue Vaccine Likely To Be Ready By 2026

India's First Dengue Vaccine Likely To Be Ready By 2026

Rediff.com   30 Jul 2024

Dengue has become a major public health concern in India with 289,235 cases reported last year. This year there were 19,447 cases of dengue which resulted in 19 deaths till April 2024.

Mankind Pharma to lead in Indian women's health market after BSV deal

Mankind Pharma to lead in Indian women's health market after BSV deal

Rediff.com   29 Jul 2024

New Delhi-based pharmaceutical major Mankind Pharma is poised to take pole position in women's health portfolio in the India Pharma Market (IPM) after completing the Rs 13,630 crore deal to acquire Bharat Serums and Vaccines (BSV), senior company officials said. The deal potentially opens doors for Mankind Pharma to the overseas markets, which currently draws 92 per cent of its revenues from India. The combined entity will draw around 13 per cent revenues from the international market, with the remaining coming from the domestic market.

Vedanta's Agarwal urges govt to privatise gold mining to boost production

Vedanta's Agarwal urges govt to privatise gold mining to boost production

Rediff.com   29 Jul 2024

Anil Agarwal, chairman of metals major Vedanta group, has called for the sale of government stake in Bharat Gold Mine and Hutti Gold Mine so as to increase production of the yellow metal in the country. In a social media post, Agarwal said global gold prices are currently at record highs and India imports 99.9 per cent of its requirement. "With massive investments, we can be a major producer of gold and a big generator of employment," Agarwal said.

Indian Biz Sees Hope After Bangladesh SC Order

Indian Biz Sees Hope After Bangladesh SC Order

Rediff.com   22 Jul 2024

'Bilateral trade has suffered seriously because of the growing unrest.' 'There is a standstill on both sides amid the curfew.'

Nipah Death Puts Kerala On Alert

Nipah Death Puts Kerala On Alert

Rediff.com   22 Jul 2024

The scare of communicable diseases seems to be gripping the country with Maharashtra reporting 28 Zika cases this year, the highest since 2021.

Downpour Of Diseases In India

Downpour Of Diseases In India

Rediff.com   20 Jul 2024

Kerala has had 202 fatalities in 2024 so far. In July alone, there were 202,122 episodes of fever, 2,250 cases of dengue, 1,850 cases of mumps and several other illnesses. 10,000 cases of dengue have been reported from Karnataka. 1,000 swine flu cases have been documented in Rajasthan.

Honda 2W share rises after on-board norms compliance

Honda 2W share rises after on-board norms compliance

Rediff.com   17 Jul 2024

The battle for the top spot in the two-wheeler market is intensifying. The gap between Hero MotoCorp and Honda Motorcycle & Scooter India (HMSI) in retail sales narrowed to just 45,607 units in June. This improvement comes as HMSI has clawed back market share after dipping to a historic low of 18 per cent in May 2023. Now, the retail market shares of the two companies are 28.86 per cent and 25.54 per cent, respectively, compared to 35.54 per cent and 18.05 per cent in May 2023.

Temasek likely to invest $10 billion in India in the next three years

Temasek likely to invest $10 billion in India in the next three years

Rediff.com   16 Jul 2024

Singapore government's sovereign wealth fund Temasek is looking to invest $10 billion in India during the next three years, Ravi Lambah, Temasek's head of India and strategic initiatives, said.

Diabetes Drug Linked To Vision Loss?

Diabetes Drug Linked To Vision Loss?

Rediff.com   16 Jul 2024

Study suggested that constant use of Semaglutide may be linked to development of a condition called non-arteritic ischemic optic neuropathy.

Tyger Capital to list by next year, targets Rs 20,000 crore book

Tyger Capital to list by next year, targets Rs 20,000 crore book

Rediff.com   12 Jul 2024

Bain Capital-backed Tyger Capital is planning to list its shares on the Indian stock exchanges by the next financial year and is targeting to grow its assets under management by four times to Rs 20,000 crore in five years from Rs 5,000 crore now, Gaurav Gupta, MD and CEO of the firm said. In an exclusive interview, Gupta said that keeping with the growing business, the finance company expects to on-board 600 people in the current financial year as it is opening 60-65 new branches for broad-basing its network in the country.

LIC's residual stake value surges in top groups on stock market boom

LIC's residual stake value surges in top groups on stock market boom

Rediff.com   8 Jul 2024

Life Insurance Corporation of India (LIC) has made the most of the stock market boom by reducing stakes in all its top conglomerates during the financial year 2023-2024 (FY24). However, even after reducing exposure, the value of its remaining stake has gone up substantially across all groups, according to data collated from stock exchange filings.

Sebi Has Strong Case Against Hindenburg

Sebi Has Strong Case Against Hindenburg

Rediff.com   4 Jul 2024

If Hindenburg or its partner do not join the investigation, then Sebi may pass an ex-parte order against it, which may be enforced as a foreign award in US courts.

How Kalki's Bujji Was Born

How Kalki's Bujji Was Born

Rediff.com   1 Jul 2024

'Fun stuff does, indeed, happen on X.'

Quality Lapses Shut Down Drug Makers

Quality Lapses Shut Down Drug Makers

Rediff.com   28 Jun 2024

Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.

Adani group to press the pedal on its retail play through super app

Adani group to press the pedal on its retail play through super app

Rediff.com   27 Jun 2024

With an existing consumer base of 400 million across airports, electricity and gas distribution businesses, the Adani group is revving up its retail play. It is planning to use the 2.4 billion consumer interactions a year with group companies to push various products and services. The group has already launched the 'Adani One' super app that will eventually sell products across the spectrum, top executives said.

Bidders of Haldiram Snacks Foods seek clarity on ownership of the brand

Bidders of Haldiram Snacks Foods seek clarity on ownership of the brand

Rediff.com   26 Jun 2024

The prospective bidders of Haldiram Snacks Foods (HSFPL), a leading food firm, have sought clarity on the ownership of the brand as it is currently owned by different family factions. The Delhi and Nagpur families have decided to merge their operations and formed a joint venture to sell part of their stake. On the other hand, the Kolkata family runs its separate, independent operations. Bankers said prospective bidders of the company do not want any confusion over the brand in future. They have sought clarity over usage of the brand.